Confirmed Control Closed Transaction verified Body Contouring DevicesConsumerMedical AestheticsMedical Aesthetics / Body Contouring DevicesNon Invasive Fat Reduction

ZELTIQ Aesthetics acquired by Allergan

Allergan acquired ZELTIQ Aesthetics, an US medical aesthetics / body contouring devices brand on Feb 13, 2017. The transaction value is shown as USD 2.5bn. The current comp implies EV / revenue of 6.2x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.

Transaction summary

Target
ZELTIQ Aesthetics
Acquirer
Allergan
Seller
-
Announced
2017-02-13
Geography
United States
Tags
Body Contouring DevicesConsumerMedical AestheticsMedical Aesthetics / Body Contouring DevicesNon Invasive Fat Reduction
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-19
Latest update
2026-06-19

Value and multiples

Price / value

USD 2.5B

Consideration | USD

Basis: Public source

EV / revenue

6.2x

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • USD 2.5bn consideration is treated as publicly disclosed or derived directly from public source data.
  • EV / revenue is shown as 6.2x based on the available comp inputs.
  • Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.

Source summary

No public source summary has been published for this transaction yet.